Cycle Pharmaceuticals Ltd
Cycle Pharmaceuticals Ltd., headquartered in Great Britain, is a prominent player in the pharmaceutical industry, specialising in the development and commercialisation of innovative treatments for rare diseases. Founded in 2013, the company has rapidly established itself as a leader in niche therapeutic areas, focusing on products that address unmet medical needs. With a strong operational presence across Europe and beyond, Cycle Pharmaceuticals is dedicated to providing unique solutions that enhance patient care. Their core offerings include a range of specialised medicines, distinguished by their commitment to quality and efficacy. The company has achieved significant milestones, including strategic partnerships and successful product launches, solidifying its market position as a trusted provider in the rare disease sector.
DitchCarbon Score
How does Cycle Pharmaceuticals Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cycle Pharmaceuticals Ltd's score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cycle Pharmaceuticals Ltd's reported carbon emissions
Cycle Pharmaceuticals Ltd, headquartered in Great Britain, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Cycle Pharmaceuticals may not have established formal commitments to reduce carbon emissions or may not publicly disclose such information. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and climate action, often setting Science-Based Targets (SBTi) to align with global climate goals. However, without specific commitments or emissions data, it is unclear how Cycle Pharmaceuticals aligns with these industry trends. As the company continues to operate, it may consider developing and communicating its climate strategy to enhance transparency and contribute to broader environmental efforts.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cycle Pharmaceuticals Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
